← back to search

Grégoire Altan‐Bonnet

Czech Academy of Sciences, Institute of Hydrology · CZ
Area of research
Immunology · Oncology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and Immunotherapy and Immune Responses.
h-index
43
citations
10,870
works
179
NIH funding
primary concept
Biology
email

Recent publications

Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Cell 2025cited by 27position: middledoi
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways
The Journal of Experimental Medicine 2023cited by 18position: middledoi
Systematic investigation of cytokine signaling activity at the tissue and single-cell levels
Nature Methods 2021cited by 251position: middledoi
A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells
Cell 2021cited by 144position: middledoi
β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway
Cell 2020cited by 642position: middledoi
Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease
Journal of Clinical Investigation 2019cited by 103position: middledoi
IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus
The Journal of Experimental Medicine 2019cited by 91position: middledoi
A Tunable Diffusion-Consumption Mechanism of Cytokine Propagation Enables Plasticity in Cell-to-Cell Communication in the Immune System
Immunity 2017cited by 204position: middledoi
Catch and Release of Cytokines Mediated by Tumor Phosphatidylserine Converts Transient Exposure into Long-Lived Inflammation
Molecular Cell 2017cited by 47position: lastdoi
EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines
Scientific Reports 2017cited by 43position: middledoi
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors
Science Signaling 2016cited by 63position: middledoi
Clonal Abundance of Tumor-Specific CD4 + T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion
Immunity 2016cited by 53position: middledoi
Phosphatidylserine Vesicles Enable Efficient En Bloc Transmission of Enteroviruses
Cell 2015cited by 477position: middledoi
T Cells Integrate Local and Global Cues to Discriminate between Structurally Similar Antigens
Cell Reports 2015cited by 73position: lastdoi
Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes
Cancer Immunology Research 2014cited by 135position: middledoi
The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
Neoplasia 2013cited by 503position: middledoi
Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses
Frontiers in Immunology 2012cited by 123position: lastdoi
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses
Proceedings of the National Academy of Sciences 2012cited by 91position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nihal Altan‐Bonnet · National Institutes of Health3 papers (2015–2020)Ronald N. Germain · National Institute of Allergy and Infectious Diseases3 papers (2017–2023) · 3 papers (2012–2017)Peng Jiang · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2021–2025)Alexander Y. Rudensky · Rockefeller University2 papers (2019–2021)Peter M. Takvorian · Rutgers, The State University of New Jersey2 papers (2015–2020)Rohit Paul · Center for Cancer Research2 papers (2021–2025)Jedd D. Wolchok · Cornell University2 papers (2014–2016)Trang Vu · Center for Cancer Research2 papers (2021–2025)Beibei Ru · University of Electronic Science and Technology of China2 papers (2021–2025)Czrina Cortez · Weill Cornell Medicine2 papers (2014–2016)Yu Zhang · Guangzhou University of Chinese Medicine2 papers (2021–2025)Jennifer E. Oyler · Harvard University2 papers (2017–2017)Alon Oyler‐Yaniv · Center for Cancer Research2 papers (2017–2017)Ying-Han Chen · Institute of Biomedical Sciences, Academia Sinica2 papers (2015–2017)Sourish Ghosh · Jadavpur University1 papers (2020–2020)Anthony R. Fehr · University of Kansas1 papers (2020–2020)Jason T. Huse · The University of Texas MD Anderson Cancer Center1 papers (2017–2017)Kyemyung Park · University of Maryland, College Park1 papers (2021–2021)Ross L. Levine · Leukemia and Lymphoma Society1 papers (2016–2016)